MDS Inc. to Sell Late Stage Research Unit for $50 Million

Bookmark and Share

Reuters -- MDS Inc said on Monday that it planned to narrow its contract research focus by selling its late stage operations and central laboratory divisions.

MORE ON THIS TOPIC